Vor Biopharma (VOR) Accumulated Depreciation (2020 - 2026)

Vor Biopharma (VOR) has reported Accumulated Depreciation for 7 consecutive years, with $53000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Depreciation fell 99.56% year-over-year to $53000.0; the TTM figure through Mar 2026 stood at $53000.0 (down 99.56% YoY), while the FY2025 annual figure was $25000.0, down 99.78% from the prior year.
• Accumulated Depreciation improved to $53000.0 in Q1 2026 per VOR's latest filing, from $25000.0 in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $12.0 million in Q1 2025 and bottomed at $1000.0 in Q3 2025.
• Historically, Accumulated Depreciation has averaged $5.9 million across 5 years, with a median of $5.9 million in 2023.
• Annual changes were most pronounced in 2022 — Accumulated Depreciation soared 142.04% — and 2025, when it plunged 99.99%.
• Vor Biopharma's Accumulated Depreciation stood at $4.6 million in 2022, then soared by 75.51% to $8.1 million in 2023, then surged by 38.6% to $11.2 million in 2024, then tumbled by 99.78% to $25000.0 in 2025, then surged by 112.0% to $53000.0 in 2026.
• Business Quant data shows VOR's Accumulated Depreciation at $53000.0 in Q1 2026, $25000.0 in Q4 2025, and $1000.0 in Q3 2025.